Company Profile Sector: Health Care Industry: Biotechnology Company Location: Cranbury, NJ Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of...
PTN gave a nice buy signal. I personally took a position here. There is a chance it could test 0.40 cent area. Stoploss below white line, take profits at colored lines above green. THIS IS NOT FINANCIAL ADVICE. DO NOT BLINDLY FOLLOW THIS TRADE.
Breakout, retest, potential triple bottom Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.
Will Women get an F&DA approval for their VIAGRA?? Good entry with LT target 4-5 if approved. This chart is for own use. Viewers come to own conclusions and appreciate comments and learning thoughts.
Earlier this year i picked up some $PTN at .41 took from some of my port's losers to throw more at this big winner. Getting some respect of the 50% fib here; As y'all know the concept of 50% is critical to ichimoku, HA candles, etc. Also getting some bullish jpn candlestick patterns with volume trending in that dir. via OBV and Volume Trend Accumulation...
PTN seems going for more upside. If it fails breaking the level posted on chart i'm looking for a short setup. A strong breakout of that level can invalidate this setup.